André Gonzaga Dos Santos

Dr. André Gonzaga Dos Santos


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2011 in Anais da Academia Brasileira de Ciências
Verified
Journal Article
Open access
PDF file
PFPaulo Michel Pinheiro Ferreira
Paulo Michel Pinheiro Ferreira
LCLeticia V. Costa-Lotufo
Leticia V. Costa-Lotufo
MMManoel O. Moraes
Manoel O. Moraes
FBFrancisco W.A. Barros
Francisco W.A. Barros
AMAline M.A. Martins
Aline M.A. Martins
Cláudia PessoaCláudia Pessoa
Cláudia Pessoa
Folk uses and scientific investigations have highlighted the importance of Casearia sylvestris extracts and their relevant bioactive potential. The aim of this work was to review the pharmacological properties of C. sylvestris, emphasizing its anti-ulcer, anti-inflammatory, anti-ophidian and antitumor potentialities. Ethanolic extracts and essential oil of their leaves have antiulcerogenic activity and reduce gastric volume without altering the stomach pH, which corroborates their consumption on gastrointestinal disorders. Leaf water extracts show phospholipase A2 inhibitory activity that prevents damage effects on the muscular tissue after toxin inoculation. This antiphospholipasic action is probably related to the use as an anti-inflammatory, proposing a pharmacological blockage similar to that obtained with non-steroidal anti-inflammatory drugs on arachidonic acid and cyclooxygenase pathways. Bioguided-assay fractionations lead to the identification of secondary metabolites, especially the clerodane diterpenes casearins (A-X) and casearvestrins (A-C), compounds with a remarkable cytotoxic and antitumor action. Therefore, the C. sylvestris shrub holds a known worldwide pharmacological arsenal by its extensive folk utilization, exciting searches for new molecules and a better comprehension about biological properties.

Verified
Journal Article
Open access
PDF file
LTLuciani De Toledo
Luciani De Toledo
MRMatheus Aparecidos Dos Santos Ramos
Matheus Aparecidos Dos Santos Ramos
LSLarissa Spósito
Larissa Spósito
ECElza Maria Castilho
Elza Maria Castilho
Fernando Rogério PavanFernando Rogério Pavan
Fernando Rogério Pavan
MAMargarete Teresa Gottardo de Almeida
Margarete Teresa Gottardo de Almeida
Background: The incidence of fungal infections, especially those caused by Candida yeasts, has increased over the last two decades. However, the indicated therapy for fungal control has limitations. Hence, medicinal plants have emerged as an alternative in the search for new antifungal agents as they present compounds, such as essential oils, with important biological effects. Published data demonstrate important pharmacological properties of the essential oil of Cymbopogon nardus (L.) Rendle; these include anti-tumor, anti-nociceptive, and antibacterial activities, and so an investigation of this compound against pathogenic fungi is interesting. Objective: The aim of this study was to evaluate the chemical composition and biological potential of essential oil (EO) obtained from the leaves of C. nardus focusing on its antifungal profile against Candida species. Methods: The EO was obtained by hydrodistillation and analyzed by gas chromatography-mass spectrometry (GC-MS). Testing of the antifungal potential against standard and clinical strains was performed by determining the minimal inhibitory concentration (MIC), time-kill, inhibition of Candida albicans hyphae growth, and inhibition of mature biofilms. Additionally, the cytotoxicity was investigated by the IC50 against HepG-2 (hepatic) and MRC-5 (fibroblast) cell lines. Results: According to the chemical analysis, the main compounds of the EO were the oxygen-containing monoterpenes: citronellal, geranial, geraniol, citronellol, and neral. The results showed important antifungal potential for all strains tested with MIC values ranging from 250 to 1000 μg/mL, except for two clinical isolates of C. tropicalis (MIC > 1000 μg/mL). The time-kill assay showed that the EO inhibited the growth of the yeast and inhibited hyphal formation of C. albicans strains at concentrations ranging from 15.8 to 1000 μg/mL. Inhibition of mature biofilms of strains of C. albicans, C. krusei and C. parapsilosis occurred at a concentration of 10× MIC. The values of the IC50 for the EO were 96.6 μg/mL (HepG-2) and 33.1 μg/mL (MRC-5). Conclusion: As a major virulence mechanism is attributed to these types of infections, the EO is a promising compound to inhibit Candida species, especially considering its action against biofilm.

1 April 2018 in Food Chemistry
Verified
Journal Article
Open access
ACA.C.C.M. Castro
A.C.C.M. Castro
FOFernando Bombarda Oda
Fernando Bombarda Oda
MCMaria Gabriela José de Almeida Cincotto
Maria Gabriela José de Almeida Cincotto
Marcelo Gomes DavançoMarcelo Gomes Davanço
Marcelo Gomes Davanço
BCBruna Chiari-Andréo
Bruna Chiari-Andréo
ASAndré Gonzaga Dos Santos
André Gonzaga Dos Santos
Oil extraction from green coffee seeds generates residual mass that is discarded by agribusiness and has not been previously studied. Bioactive secondary metabolites in coffee include antioxidant phenolic compounds, such as chlorogenic acids. Coffee seeds also contain caffeine, a pharmaceutically important methylxanthine. Here, we report the chemical profile, antioxidant activity, and cytotoxicity of hydroethanolic extracts of green Coffea arabica L. seed residue. The extracts of the green seeds and the residue have similar chemical profiles, containing the phenolic compounds chlorogenic acid and caffeine. Five monoacyl and three diacyl esters of trans-cinnamic acids and quinic acid were identified by ultra-performance liquid chromatography/electrospray ionization-quadruple time of flight mass spectrometry. The residue extract showed antioxidant potential in DPPH, ABTS, and pyranine assays and low cytotoxicity. Thus, coffee oil residue has great potential for use as a raw material in dietary supplements, cosmetic and pharmaceutical products, or as a source of bioactive compounds.

20 January 2010 in Chemistry & Biodiversity
Verified
Journal Article
Closed access
PDF file
ASAndré Gonzaga Dos Santos
André Gonzaga Dos Santos
PFPaulo Michel Pinheiro Ferreira
Paulo Michel Pinheiro Ferreira
GJGerardo Magela Vieira Junior
Gerardo Magela Vieira Junior
CPCarla Cristina Perez
Carla Cristina Perez
ATAristeu Gomes Tininis
Aristeu Gomes Tininis
ACAlberto José Cavalheiro
Alberto José Cavalheiro

1 December 2010 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
PFPaulo Michel Pinheiro Ferreira
Paulo Michel Pinheiro Ferreira
ASAndré Gonzaga Dos Santos
André Gonzaga Dos Santos
ATAristeu G. Tininis
Aristeu G. Tininis
PCPatricia M. Costa
Patricia M. Costa
ACAlberto J. Cavalheiro
Alberto J. Cavalheiro
CPCláudia Pessoa
Cláudia Pessoa

1 November 2017 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
KMKaila P. Medina-Alarcón
Kaila P. Medina-Alarcón
AVAline R. Voltan
Aline R. Voltan
BFBruno Fonseca-Santos
Bruno Fonseca-Santos
IMIsabela Jacob Moro
Isabela Jacob Moro
FSFelipe de Oliveira Souza
Felipe de Oliveira Souza
AFAna M. Fusco-Almeida
Ana M. Fusco-Almeida